Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Ultragenyx Pharmaceutical Inc.

RARE

Valuace

Růst

Zdraví

Cena

$ 21.42

-1.01 (-4.30%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Total Revenues	672.7	673.0	560.2	434.2	363.3	351.4	271.0	103.7	51.5	2.6	0.1	0.0	0.0	0.0	0.0	0.0
Cost of Revenues	108.7	109.0	76.7	45.2	28.3	16.0	6.1	9.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross Profit	564.1	564.0	483.5	389.0	335.0	335.4	264.9	94.7	50.3	2.6	0.1	0.0	0.0	0.0	0.0	0.0

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	207.0	159.9	166.5	139.3	164.9	139.5	147.0	108.8	127.4	98.1
Cost of Revenues	29.0	28.0	23.0	28.7	16.9	21.0	21.3	17.5	12.1	11.0
Gross Profit	178.0	131.9	143.5	110.6	148.0	118.5	125.7	91.3	115.3	87.1

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
R&D Expenses	0.0	0.0	0.0	648.4	705.8	497.2	412.1	357.4	294.0	231.6	183.2	114.7	46.0	27.8	12.6	4.7
Selling General & Admin Expenses	0.0	0.0	0.0	309.8	278.1	220.0	182.9	161.5	127.7	99.9	64.9	33.0	10.8	4.5	3.3	1.8
Depreciation & Amortization	35.0	35.0	35.5	26.0	9.5	0.2	7.6	12.5	19.5	5.8	3.4	1.4	0.7	0.4	0.3	0.0
Total Operating Expenses	1,099.8	1,099.0	1,019.5	958.2	983.9	717.1	595.0	518.9	421.7	331.6	248.1	147.7	56.8	32.3	16.0	6.6
Operating Income	-535.7	-535.0	-536.0	-569.2	-648.9	-381.7	-330.1	-424.2	-371.4	-328.9	-248.0	-147.7	-56.8	-32.3	-16.0	-6.6

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.6	157.2
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	74.9
Depreciation & Amortization	8.8	8.6	8.6	9.0	9.1	8.8	8.9	8.8	8.2	7.2
Total Operating Expenses	292.0	302.8	251.4	253.6	270.3	250.5	242.1	256.6	237.4	232.2
Operating Income	-114.0	-170.9	-107.9	-142.9	-122.3	-132.0	-116.4	-165.3	-122.0	-145.1

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Interest Income	25.0	25.0	36.5	26.7	11.1	1.9	7.0	13.2	9.5	4.1	3.8	2.3	0.6	0.2	0.0	0.0
Interest Expense	61.5	62.0	63.0	66.0	43.0	29.4	33.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
Other Expense	-35.6	-36.0	-31.6	-39.3	-52.8	-71.2	144.8	24.7	174.3	10.6	2.2	-0.2	-3.0	-3.0	-0.4	0.0
IBT	-571.3	-571.0	-567.6	-608.5	-701.7	-453.0	-185.4	-399.4	-197.1	-318.3	-245.8	-145.6	-59.8	-35.1	-16.3	-6.8
Income Tax Expense	4.1	4.0	1.6	-1.8	5.7	1.0	1.2	3.3	0.5	-16.2	0.0	-2.3	-0.7	-3.0	-0.4	0.2
Net Income	-575.4	-575.0	-569.2	-606.6	-707.4	-454.0	-186.6	-402.7	-197.6	-302.1	-245.9	-145.6	-59.8	-35.1	-16.3	-6.8

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	6.5	5.9	5.8	6.8	9.6	10.7	7.4	8.8	8.6	5.9
Interest Expense	19.0	14.1	14.0	14.3	15.5	15.7	16.0	15.8	17.3	17.7
Other Expense	-14.0	-8.7	-6.1	-6.8	-11.1	-1.2	-14.4	-4.9	-4.8	-13.9
IBT	-128.0	-179.5	-114.0	-149.8	-133.4	-133.2	-130.7	-170.2	-126.9	-159.0
Income Tax Expense	1.0	0.9	0.9	1.3	0.0	0.3	0.9	0.5	-3.7	0.7
Net Income	-129.0	-180.4	-115.0	-151.1	-133.4	-133.5	-131.6	-170.7	-123.2	-159.6

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
EPS	$0.00	$0.00	$0.00	$-8.25	$-10.12	$-6.70	$-3.07	$-7.12	$-3.97	$-7.12	$-6.21	$-3.96	$-2.08	$-1.21	$-0.71	$-0.30
EPS Diluted	$0.00	$0.00	$0.00	$-8.25	$-10.12	$-6.70	$-3.07	$-7.12	$-3.97	$-7.12	$-6.21	$-3.96	$-2.08	$-1.21	$-0.71	$-0.30
Shares Outstanding	99.9	98.6	90.5	73.5	69.9	67.8	60.8	56.6	49.8	42.5	39.6	36.8	28.8	29.1	23.1	23.1
Diluted Shares Outstanding	99.9	98.6	90.5	73.5	69.9	67.8	60.8	56.6	49.8	42.5	39.6	36.8	28.8	29.1	23.1	23.1

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-1.52	$-2.23
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-1.52	$-2.23
Shares Outstanding	99.9	99.8	98.5	96.3	95.7	95.5	86.6	84.3	81.1	71.7
Diluted Shares Outstanding	99.9	99.8	98.5	96.3	95.7	95.5	86.6	84.3	81.1	71.7

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Cash And Equivalents	486.9	173.7	213.6	132.9	307.6	713.5	433.6	113.4	100.5	161.1	93.6	24.3	7.4	86.2	10.6
Short Term Investments	283.1	436.3	363.6	614.8	432.6	488.0	321.6	346.3	134.0	219.0	343.4	163.2	46.0	0.0	0.0
Total Cash & ST Investments	770.0	610.0	577.2	896.7	999.1	1,212.0	760.4	459.7	244.5	498.1	437.0	187.5	53.4	86.2	10.6
Accounts Receivable	108.3	121.8	73.4	40.4	28.4	23.1	32.8	12.7	5.2	0.0	0.0	0.0	0.0	0.0	0.1
Inventory	40.1	45.0	34.0	26.8	16.2	13.0	11.5	7.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Assets	46.2	40.3	47.6	68.9	-187.2	47.1	46.2	42.9	29.2	21.5	13.2	5.9	1.8	0.3	0.2
Total Current Assets	964.6	817.1	732.2	883.9	856.6	1,295.3	851.0	522.4	244.5	498.1	450.2	187.5	55.2	86.4	11.0

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	202.5	166.1	127.1	173.7	150.6	480.7	112.3	213.6	72.6	102.1
Short Term Investments	222.7	311.3	367.4	436.3	471.0	283.1	299.8	363.6	369.5	449.9
Total Cash & ST Investments	425.2	477.4	494.4	610.0	621.6	763.8	412.1	777.1	524.2	552.0
Accounts Receivable	112.5	124.5	98.8	121.8	93.3	106.0	100.3	73.4	79.3	70.5
Inventory	52.2	46.5	46.0	45.0	43.3	40.1	35.9	34.0	31.8	28.3
Other Current Assets	53.2	71.4	59.8	40.3	41.4	54.7	47.7	47.6	46.0	51.4
Total Current Assets	643.2	719.8	699.2	817.1	799.6	964.6	596.0	732.2	524.2	702.1

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Property, Plant & Equipment	278.7	265.9	290.6	285.7	176.2	114.0	74.7	20.0	21.8	17.1	7.4	3.0	1.3	1.4	0.8
Goodwill	44.4	44.4	44.4	44.4	44.4	44.4	44.4	44.4	44.4	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	166.2	178.3	166.3	160.1	130.8	131.1	129.0	129.2	141.5	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	114.1	135.0	199.9	154.5	293.9	165.9	32.9	0.0	10.0	118.0	99.3	0.0	0.0	0.0	0.0
Other Long-Term Assets	50.4	62.7	57.7	16.8	20.6	8.8	3.5	3.5	3.4	-92.5	2.7	7.4	3.1	0.5	0.4
Total Long-Term Assets	653.8	686.3	758.8	661.5	665.8	464.3	284.5	197.2	246.3	42.5	109.4	10.5	4.4	1.9	1.2
Total Assets	1,618.4	1,503.5	1,491.0	1,545.4	1,522.4	1,759.6	1,135.5	719.6	490.8	540.6	559.6	198.0	59.6	88.3	12.1

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	250.0	255.8	260.9	265.9	272.4	278.7	285.1	290.6	323.2	308.2
Goodwill	44.4	44.4	44.4	44.4	44.4	44.4	44.4	44.4	44.4	44.4
Intangible Assets	172.9	174.7	176.5	178.3	164.9	166.2	165.0	166.3	157.3	158.2
Long-Term Investments	22.1	51.5	68.6	135.0	203.1	110.7	156.6	199.9	4.0	71.8
Other Long-Term Assets	57.9	60.1	62.4	62.7	53.9	53.8	60.0	51.7	110.0	26.5
Total Long-Term Assets	547.2	586.5	612.8	686.3	738.8	653.8	711.1	758.8	714.0	609.2
Total Assets	1,190.4	1,306.3	1,311.9	1,503.5	1,538.4	1,618.4	1,307.1	1,491.0	1,238.1	1,311.3

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Accounts Payable	59.8	38.8	42.1	43.3	17.1	12.9	12.9	12.3	8.9	5.4	2.9	4.9	1.4	1.2	0.3
Short-Term Debt	58.6	10.3	12.6	11.8	11.1	9.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	154.4	295.1	225.7	204.7	145.6	108.5	83.2	62.5	56.1	54.9	25.0	7.7	4.5	2.0	0.7
Current Liabilities	272.9	344.2	280.4	261.2	181.4	189.6	103.3	74.7	71.0	60.3	27.9	12.5	5.9	3.2	1.0

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	40.6	34.2	47.5	38.8	36.0	59.8	41.0	42.1	33.4	42.1
Short-Term Debt	77.7	11.8	10.5	10.3	10.4	11.7	12.8	12.6	12.1	10.9
Other Current Liabilities	221.8	247.2	233.7	295.1	238.6	201.3	191.8	225.7	208.6	191.4
Current Liabilities	340.0	293.2	291.7	344.2	285.0	272.9	245.6	280.4	254.0	244.4

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Long-Term Debt	842.2	30.0	30.6	19.8	30.9	39.3	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Leases	25.7	40.3	43.2	31.6	42.0	48.2	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	30.1	30.1	30.1	31.7	33.3	33.3	33.3	31.2	31.2	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	1,186.0	1,241.2	1,215.6	1,193.0	599.8	605.2	481.7	110.7	107.3	66.7	28.5	13.0	9.5	4.0	1.5

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	785.4	24.5	27.8	30.0	23.7	25.7	28.0	30.6	34.6	14.8
Capital Leases	33.8	36.3	38.3	40.3	34.1	37.5	40.8	43.2	12.1	25.7
Def. Tax Liability	0.0	30.1	30.1	30.1	30.1	30.1	30.1	30.1	31.7	31.7
Total Liabilities	1,174.3	1,148.0	1,160.7	1,241.2	1,184.5	1,186.0	1,166.8	1,215.6	1,206.4	1,182.3

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	-3,689.9	-3,956.8	-3,387.7	-2,781.0	-2,073.6	-1,619.6	-1,433.0	-1,030.3	-832.7	-530.5	-284.7	-139.0	-74.8	-27.1	-8.2
Comprehensive Income	2.3	-0.6	0.6	-6.6	-1.4	0.7	-0.1	-0.6	-5.7	0.9	-0.9	-0.2	0.0	-0.4	0.0
Total Common Equity	432.4	255.3	275.4	352.5	922.6	1,154.4	653.8	608.9	383.5	474.0	531.1	184.9	50.1	84.3	10.6

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Retained Earnings	-4,403.3	-4,222.9	-4,107.9	-3,956.8	-3,823.5	-3,689.9	-3,558.3	-3,387.7	-3,264.5	-3,104.8
Comprehensive Income	8.8	-0.3	-0.3	-0.6	0.9	-1.1	-0.4	0.6	-2.2	-3.1
Total Common Equity	9.2	151.3	144.2	255.3	346.8	432.4	140.3	275.4	31.7	129.0

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Total Debt		926.5	40.3	43.2	31.6	42.0	48.2	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		432.4	262.3	275.4	352.5	922.6	1,154.4	653.8	608.9	383.5	474.0	531.1	184.9	50.1	84.3	10.6

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		7.0	7.0	7.0	7.0	7.0	0.0	0.0	0.0	0.0	0.0
Book Value		9.2	151.3	144.2	255.3	346.8	432.4	140.3	275.4	31.7	129.0

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Income	-585.1	-575.0	-569.2	-606.6	-707.4	-454.0	-186.6	-402.7	-197.6	-302.1	-245.9	-145.6	-59.8	-35.1	-16.3	-6.8
Depreciation & Amortization	33.1	0.0	35.5	26.0	18.2	13.2	12.3	8.5	19.5	5.8	3.4	1.4	0.7	0.4	0.3	0.0
Stock-Based Compensation	144.9	153.0	158.0	135.2	130.4	105.0	85.7	82.0	80.1	68.0	48.3	24.9	5.4	0.7	0.9	0.3
Change Working Capital	-23.6	-23.0	13.9	-15.1	60.2	-63.2	104.7	-15.9	-24.8	-20.2	26.3	7.7	2.2	-1.5	2.3	0.5
Change In Accounts Receivable	-27.9	-31.0	-33.6	-22.8	-12.1	-5.4	9.8	-20.1	-7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Change In Accounts Payable	13.1	24.0	47.0	2.4	87.4	2.8	29.6	20.6	3.4	3.5	2.5	-2.0	3.2	0.2	0.9	0.3
Change In Inventories	-11.7	-6.0	-11.2	-6.9	-9.7	-3.1	-1.3	-4.5	-5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-cash Items	252.5	-21.0	-52.5	-12.7	119.8	11.7	21.5	1.7	-0.2	10.9	0.7	5.6	6.9	4.3	0.3	0.3
Cash from Operations	-469.5	0.0	0.0	-474.8	-380.5	-338.7	-132.2	-345.4	-290.6	-253.8	-161.0	-106.0	-44.6	-31.2	-12.5	-5.8

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	-129.0	-180.4	-115.0	-151.1	-133.4	-133.5	-131.6	-170.7	-123.2	-159.6
Depreciation & Amortization	0.0	8.6	-11.8	9.0	9.1	8.8	8.9	8.8	8.2	7.2
Stock-Based Compensation	38.0	37.0	38.5	39.9	40.2	41.6	39.4	36.9	33.7	34.9
Change Working Capital	0.6	54.9	-21.8	-56.6	22.8	30.8	16.4	-56.0	13.3	2.8
Change In Accounts Receivable	-33.8	5.4	-12.7	10.1	-20.6	9.8	2.2	-24.9	1.0	-6.2
Change In Accounts Payable	37.0	45.1	-9.7	-48.5	0.0	0.0	25.3	-35.5	15.9	7.5
Change In Inventories	0.2	-5.6	0.2	-0.8	-2.5	-2.5	-4.1	-2.1	-2.0	-3.5
Other Non-cash Items	-9.4	-11.5	1.7	-7.7	-18.1	-14.6	-10.0	-9.8	123.2	-1.8
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-83.9	-117.9

Cash Flow From Investing Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Capital Expenditure	-23.0	-7.5	-44.3	-146.1	-73.1	-43.9	-24.8	-4.1	-2.8	-10.2	-5.0	-2.1	-0.4	-1.1	-0.5
Acquisitions	2.5	0.0	0.0	-75.0	0.0	0.0	0.0	0.0	-142.8	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-386.4	-408.6	-526.4	-614.7	-1,012.2	-850.3	-707.2	-509.8	-230.5	-442.5	-624.2	-209.0	-64.0	0.0	0.0
Sales of Investment	524.5	413.3	746.2	545.1	890.9	720.6	719.0	310.2	431.6	543.8	338.4	88.0	16.6	0.0	0.0
Other Investing Activities	-2.8	0.0	-7.5	-0.8	-0.9	-5.6	0.0	170.3	0.9	-1.2	-1.5	-0.3	0.0	-0.1	-0.4
Cash from Investing	112.3	0.0	168.0	-291.7	-195.4	-179.1	-13.0	-33.3	56.4	89.9	-292.4	-123.4	-47.7	-1.2	-0.9

Cash Flow From Investing Activities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-1.3	-2.5	-1.3	-0.7	-1.6	-2.0	-3.2	-1.6	-3.7
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0
Investments	0.0	-15.5	0.0	-15.9	-367.4	-3.4	-21.9	-221.6	-139.5
Sales of Investment	0.0	89.4	137.0	119.4	93.7	68.5	131.6	116.4	207.9
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.3	-0.4
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-107.0	64.3

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.9	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	900.8	40.3	-2.8	11.6	-10.4	-6.3	11.2	37.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0
Issuance of Common Stock	769.2	0.0	0.0	379.8	10.8	78.9	511.2	355.2	309.0	132.0	79.5	467.6	189.3	0.2	0.1	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-4.3	0.0	0.0	0.0
Other Financing Activities	740.7	0.0	0.0	8.4	490.4	39.6	89.1	324.1	27.8	9.3	59.2	0.0	0.0	0.0	89.1	17.3
Cash from Financing	740.7	0.0	0.0	388.1	501.2	118.6	600.3	679.3	336.9	136.3	138.7	467.6	185.0	0.2	89.2	17.3

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	863.1	826.8	-2.0	-2.1	6.3	-3.4	-3.3	-2.4	31.1	-13.7
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.5	24.8
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	330.6	25.2

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Change in Cash		387.1	253.5	-35.2	81.8	-172.0	-416.7	290.1	320.7	12.5	-60.6	67.6	69.2	16.9	-78.8	75.5	10.6
Closing Cash Balance		486.9	436.0	184.2	219.4	137.6	309.6	726.3	436.2	115.5	100.5	161.1	93.6	24.3	7.4	86.2	10.6

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		221.7	26.1	49.5	-45.0	23.9	-330.0	367.9	-97.0	144.8	-29.1
Closing Cash Balance		436.0	214.7	188.6	139.2	184.2	160.2	490.3	122.4	219.4	78.6

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Free Cash Flow		-492.5	-472.0	-421.7	-521.6	-526.6	-411.8	-176.1	-370.2	-294.6	-256.6	-171.2	-110.9	-46.8	-31.6	-13.6	-6.4
Real Free Cash Flow		-637.4	-625.0	-579.7	-656.8	-657.0	-516.7	-261.9	-452.2	-374.7	-324.7	-219.5	-135.8	-52.2	-32.3	-14.5	-6.6

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		-100.8	-92.7	-95.7	-182.8	-80.2	-68.6	-81.5	-203.9	-85.5	-121.6
Real Free Cash Flow		-138.8	-129.7	-134.3	-222.7	-120.3	-110.2	-120.8	-240.9	-119.2	-156.4